.Welcome to this week's Chutes & Ladders, our summary of notable leadership hirings, firings and ...
.Complying with an inadequate revealing for Lykos Therapies' MDMA applicant for post-traumatic stres...
.AN2 Therapies is reviewing its own service in feedback to uninspired midphase information, vowing t...
.Merck & Co. is spending $700 million ahead of time to challenge Amgen in a blood stream cancer m...
.With Gilead Sciences about to an FDA selection for its liver ailment medicine seladelpar, the provi...
.CEO David Ricks may see the firms setting up tents at basecamp responsible for Eli Lilly in a try t...
.Bed mattress Liquidators has actually switched Entero Therapies white as a piece. The financial ins...
.Exelixis is losing hope on its own cells element (TF)- targeting antibody-drug conjugate after endi...
.3 full weeks after Roche's Genentech device walked away from an SHP2 prevention contract, Relay The...
.Stoke Therapeutics' Dravet syndrome medication has been actually freed from a predisposed hold, get...